Table 5.
Cyp450s | AUCmetabolite/AUCparent drug by intragastric administration (in vivo) |
AUCmetabolite/AUCparent drug by intravenous administration (in vivo) |
Incubation by liver microsomes (in vitro) |
Protein expression (in vitro) |
||||||
---|---|---|---|---|---|---|---|---|---|---|
Control | NASH | Change trend | Control | NASH | Change trend | Control | NASH | Control | NASH | |
Cyp2c29 | 0.138 ± 0.046 | 0.031 ± 0.022*** | ↓ | 0.241 ± 0.210 | 0.063 ± 0.034* | ↓ | − | ↓ | − | ↓ |
Cyp1a2 | 4.612 ± 1.017 | 5.075 ± 1.245 | − | 0.015 ± 0.008 | 0.019 ± 0.009 | − | − | ↓ | − | ↓ |
Cyp3a11 | 8.540 ± 1.215 | 7.950 ± 1.945 | − | 0.697 ± 0.331 | 0.956 ± 0.582 | − | − | ↓ | − | ↓ |
Cyp2c65 | 0.137 ± 0.056 | 0.065 ± 0.027** | ↓ | 0.071 ± 0.035 | 0.034 ± 0.019* | ↓ | − | ↓ | − | ↓ |
Cyp2e1 | 0.986 ± 0.327 | 0.632 ± 0.527 | − | 0.093 ± 0.039 | 0.090 ± 0.055 | − | − | − | − | ↓ |
Cyp2d22 | 0.175 ± 0.090 | 0.167 ± 0.033 | − | 0.013 ± 0.005 | 0.009 ± 0.007 | − | − | − | − | − |
Note: Data are mean ± SD; *p < 0.05, **p < 0.01, ***p < 0.001 versus control group. −: not significant. ↓: significantly decreased.